https://www.selleckchem.com/pr....oducts/enfortumab-ve
CD8+ T cells are important antiviral effectors that can potentiate long-lived immunity against COVID-19, but a detailed characterization of these cells has been hampered by technical challenges. We screened 21 well-characterized, longitudinally-sampled convalescent donors that recovered from mild COVID-19 against a collection of SARS-CoV-2 tetramers, and identified one participant with an immunodominant response against Nuc 322-331 , a peptide that is conserved in all the SARS-CoV-2 variants-of-concern reported to date.
Like
Comment
Share
